Fifth Third Bancorp Has $315,000 Position in Omega Healthcare Investors, Inc. $OHI

Fifth Third Bancorp lowered its position in Omega Healthcare Investors, Inc. (NYSE:OHI) by 48.1% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 8,606 shares of the real estate investment trust’s stock after selling 7,976 shares during the quarter. Fifth Third Bancorp’s holdings in Omega Healthcare Investors were worth $315,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds also recently made changes to their positions in the company. NBC Securities Inc. acquired a new position in shares of Omega Healthcare Investors in the first quarter valued at approximately $29,000. MassMutual Private Wealth & Trust FSB increased its stake in shares of Omega Healthcare Investors by 562.3% in the second quarter. MassMutual Private Wealth & Trust FSB now owns 1,828 shares of the real estate investment trust’s stock valued at $67,000 after buying an additional 1,552 shares during the period. UMB Bank n.a. increased its position in Omega Healthcare Investors by 94.9% during the 1st quarter. UMB Bank n.a. now owns 2,175 shares of the real estate investment trust’s stock valued at $83,000 after purchasing an additional 1,059 shares during the period. Meeder Asset Management Inc. increased its position in Omega Healthcare Investors by 1,581.3% during the 1st quarter. Meeder Asset Management Inc. now owns 2,522 shares of the real estate investment trust’s stock valued at $96,000 after purchasing an additional 2,372 shares during the period. Finally, Montag A & Associates Inc. increased its position in Omega Healthcare Investors by 101.8% during the 1st quarter. Montag A & Associates Inc. now owns 3,015 shares of the real estate investment trust’s stock valued at $115,000 after purchasing an additional 1,521 shares during the period. Institutional investors and hedge funds own 65.25% of the company’s stock.

Omega Healthcare Investors Price Performance

Shares of OHI opened at $42.21 on Wednesday. Omega Healthcare Investors, Inc. has a 12-month low of $35.04 and a 12-month high of $44.42. The business’s fifty day moving average is $41.26 and its 200 day moving average is $38.63. The company has a quick ratio of 7.10, a current ratio of 7.10 and a debt-to-equity ratio of 0.96. The stock has a market cap of $12.45 billion, a P/E ratio of 26.06, a P/E/G ratio of 2.18 and a beta of 0.71.

Omega Healthcare Investors (NYSE:OHI) last issued its earnings results on Thursday, July 31st. The real estate investment trust reported $0.77 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.45 by $0.32. Omega Healthcare Investors had a return on equity of 9.78% and a net margin of 42.23%.The company had revenue of $235.60 million for the quarter, compared to analysts’ expectations of $248.49 million. During the same period last year, the business earned $0.71 EPS. Omega Healthcare Investors’s quarterly revenue was up 11.8% compared to the same quarter last year. Omega Healthcare Investors has set its FY 2025 guidance at 3.040-3.070 EPS. Sell-side analysts anticipate that Omega Healthcare Investors, Inc. will post 2.86 earnings per share for the current fiscal year.

Omega Healthcare Investors Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, August 15th. Investors of record on Monday, August 4th were issued a $0.67 dividend. This represents a $2.68 dividend on an annualized basis and a dividend yield of 6.3%. The ex-dividend date was Monday, August 4th. Omega Healthcare Investors’s dividend payout ratio (DPR) is currently 165.43%.

Insiders Place Their Bets

In other Omega Healthcare Investors news, Director Lisa Egbuonu-Davis sold 2,500 shares of the firm’s stock in a transaction on Friday, August 8th. The stock was sold at an average price of $40.16, for a total transaction of $100,400.00. Following the transaction, the director directly owned 18,654 shares in the company, valued at approximately $749,144.64. This trade represents a 11.82% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 1.50% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of analysts have weighed in on OHI shares. Royal Bank Of Canada increased their target price on shares of Omega Healthcare Investors from $39.00 to $41.00 and gave the company a “sector perform” rating in a research report on Thursday, August 7th. Wells Fargo & Company increased their target price on shares of Omega Healthcare Investors from $41.00 to $44.00 and gave the company an “overweight” rating in a research report on Wednesday, August 27th. Raymond James Financial reissued an “outperform” rating on shares of Omega Healthcare Investors in a research report on Tuesday, September 2nd. Truist Financial increased their target price on shares of Omega Healthcare Investors from $39.00 to $44.00 and gave the company a “hold” rating in a research report on Wednesday, September 3rd. Finally, Mizuho increased their target price on shares of Omega Healthcare Investors from $37.00 to $40.00 and gave the company a “neutral” rating in a research report on Thursday, September 11th. Five investment analysts have rated the stock with a Buy rating and five have issued a Hold rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $43.75.

About Omega Healthcare Investors

Omega Healthcare Investors, Inc engages in the provision of financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities, assisted living facilities, independent living facilities, rehabilitation and acute care facilities, and medical office buildings.